The US, Japan and Europe are the world’s largest medtech markets. Together they account for almost half of the global market and it is fair to state that they have comparable patient buying power, quality and scope of healthcare infrastructure, and sophistication of clinical practices.
However, due to variations in 4 key domains, their approach to purchasing medical devices and technologies is inevitably different.
> Procurement processes and negotiation approaches
> Decision-maker weightings
> Distributor infrastructures
Key business intelligence insight includes the understanding of the mechanisms behind the adoption and integration of new and innovative technologies.
It is crucial to understand these clear or nuanced variations in order to access the market successfully.
Download the whitepaper ‘Business Intelligence in Difficult Medtech Markets – Finding the differences in the USA, Japan and Europe’ to understand the differences in these high potential markets, and use it to optimize your medtech strategy.